{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:26Z","timestamp":1744172906736,"version":"3.40.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00277-009-0711-0","type":"journal-article","created":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T20:13:39Z","timestamp":1235420019000},"page":"999-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens"],"prefix":"10.1007","volume":"88","author":[{"given":"Carsten","family":"Zwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dieter","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Kubuschok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Held","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Ahlgrimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Bittenbring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,24]]},"reference":[{"key":"711_CR1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","volume":"18","author":"JM Foran","year":"2000","unstructured":"Foran JM, Rohatiner AZ, Cunningham D, Popescu RA, Solal-Celigny P, Ghielmini M, Coiffier B, Johnson PW, Gisselbrecht C, Reyes F, Radford JA, Bessell EM, Souleau B, Benzohra A, Lister TA (2000) European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol 18:317\u2013324","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"711_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/A:1008309405678","volume":"11","author":"JM Foran","year":"2000","unstructured":"Foran JM, Cunningham D, Coiffier B, Solal-Celigny P, Reyes F, Ghielmini M, Johnson PW, Gisselbrecht C, Bradburn M, Matthews J, Lister TA (2000) Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Ann Oncol 11(Suppl 1):117\u2013121. doi:10.1023\/A:1008309405678","journal-title":"Ann Oncol"},{"issue":"3","key":"711_CR3","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, Eriksson M, Nordstrom M, Kimby E, Boesen AM, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Akerman M, Ehinger M, Sundstrom C, Langholm R, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E (2008) Long-term progression-free survival of mantle cell lymphoma following intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a non-randomized phase-II multicenter study by the Nordic Lymphoma Group. Blood 112(3):2687\u20132693","journal-title":"Blood"},{"key":"711_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1023\/A:1008380527502","volume":"10","author":"IF Khouri","year":"1999","unstructured":"Khouri IF, Lee MS, Romaguera J, Mirza N, Kantarjian H, Korbling M, Albitar M, Giralt S, Samuels B, Anderlini P, Rodriguez J, von Wolff B, Gajewski J, Cabanillas F, Champlin R (1999) Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. Ann Oncol 10:1293\u20131299. doi:10.1023\/A:1008380527502","journal-title":"Ann Oncol"},{"key":"711_CR5","first-page":"1337","volume":"28","author":"CM Munger","year":"2006","unstructured":"Munger CM, Vose JM, Joshi SS (2006) Dendritic cell-based therapy for mantle cell lymphoma. Int J Oncol 28:1337\u20131343","journal-title":"Int J Oncol"},{"key":"711_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0301-472X(99)00057-0","volume":"27","author":"L Chaperot","year":"1999","unstructured":"Chaperot L, Delfau-Larue MH, Jacob MC, Molens JP, Roussel B, Agrawal S, Farcet JP, Gressin R, Sotto JJ, Bensa JC, Plumas J (1999) Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas. Exp Hematol 27:1185\u20131193. doi:10.1016\/S0301-472X(99) 00057-0","journal-title":"Exp Hematol"},{"key":"711_CR7","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V92.4.1184","volume":"92","author":"TA Davis","year":"1998","unstructured":"Davis TA, Maloney DG, Czerwinski DK, Liles TM, Levy R (1998) Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone. Blood 92:1184\u20131190","journal-title":"Blood"},{"key":"711_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/asheducation-2001.1.221","volume":"2001","author":"OW Press","year":"2001","unstructured":"Press OW, Leonard JP, Coiffier B, Levy R, Timmerman J (2001) Immunotherapy of non-Hodgkin's lymphomas. Hematology 2001:221\u2013240. doi:10.1182\/asheducation-2001.1.221","journal-title":"Hematology"},{"key":"711_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0145-2126(02)00217-5","volume":"27","author":"R Proto-Siqueira","year":"2003","unstructured":"Proto-Siqueira R, Falcao RP, de Souza CA, Ismael SJ, Zago MA (2003) The expression of PRAME in chronic lymphoproliferative disorders. Leuk Res 27:393\u2013396. doi:10.1016\/S0145-2126(02) 00217-5","journal-title":"Leuk Res"},{"key":"711_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","volume":"6","author":"H Ikeda","year":"1997","unstructured":"Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199\u2013208. doi:10.1016\/S1074-7613(00) 80426-4","journal-title":"Immunity"},{"key":"711_CR11","first-page":"167","volume":"9","author":"X Xie","year":"2003","unstructured":"Xie X, Wacker HH, Huang S, Regitz E, Preuss KD, Romeike B, Parwaresch R, Tiemann M, Pfreundschuh M (2003) Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas. Clin Cancer Res 9:167\u2013173","journal-title":"Clin Cancer Res"},{"key":"711_CR12","first-page":"4766","volume":"56","author":"O Tureci","year":"1996","unstructured":"Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M (1996) The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56:4766\u20134772","journal-title":"Cancer Res"},{"key":"711_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction. Anal Biochem 162:156\u2013159. doi:10.1016\/0003-2697(87) 90021-2","journal-title":"Anal Biochem"},{"key":"711_CR14","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1074\/jbc.272.10.6416","volume":"272","author":"O Tureci","year":"1997","unstructured":"Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U (1997) Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272:6416\u20136422. doi:10.1074\/jbc.272.10.6416","journal-title":"J Biol Chem"},{"key":"711_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","volume":"35","author":"G Hale","year":"1990","unstructured":"Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens 35:118\u2013127. doi:10.1111\/j.1399-0039.1990.tb01767.x","journal-title":"Tissue Antigens"},{"key":"711_CR16","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1098\/rstb.2005.1702","volume":"360","author":"H Waldmann","year":"2005","unstructured":"Waldmann H, Hale G (2005) CAMPATH: from concept to clinic. Philos Trans R Soc Lond B Biol Sci 360:1707\u20131711. doi:10.1098\/rstb.2005.1702","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"711_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2141.2003.04587.x","volume":"123","author":"S Guyomard","year":"2003","unstructured":"Guyomard S, Salles G, Coudurier M, Rousset H, Coiffier B, Bienvenu J, Fabien N (2003) Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma. Br J Haematol 123:90\u201399. doi:10.1046\/j.1365-2141.2003.04587.x","journal-title":"Br J Haematol"},{"key":"711_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clim.2006.05.006","volume":"120","author":"T Watanabe","year":"2006","unstructured":"Watanabe T, Masuyama J, Sohma Y, Inazawa H, Horie K, Kojima K, Uemura Y, Aoki Y, Kaga S, Minota S, Tanaka T, Yamaguchi Y, Kobayashi T, Serizawa I (2006) CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells. Clin Immunol 120:247\u2013259. doi:10.1016\/j.clim.2006.05.006","journal-title":"Clin Immunol"},{"key":"711_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3816\/CLM.2006.n.029","volume":"6","author":"DD Santos","year":"2006","unstructured":"Santos DD, Hatjiharissi E, Tournilhac O, Chemaly MZ, Leleu X, Xu L, Patterson C, Branagan AR, Manning RJ, Ho AW, Hunter ZR, Dimmock EA, Kutok JL, Churchill WH, Castells MC, Tai YT, Anderson KC, Treon SP (2006) CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's macroglobulinemia and mast cell disorders. Clin Lymphoma Myeloma 6:478\u2013483. doi:10.3816\/CLM.2006.n.029","journal-title":"Clin Lymphoma Myeloma"},{"key":"711_CR20","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1158\/1078-0432.CCR-06-1275","volume":"12","author":"SJ Rodig","year":"2006","unstructured":"Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL (2006) Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res 12:7174\u20137179. doi:10.1158\/1078-0432.CCR-06-1275","journal-title":"Clin Cancer Res"},{"issue":"5)","key":"711_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cyto.b.20181","volume":"72","author":"M Klabusay","year":"2007","unstructured":"Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J (2007) Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34(+) cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Cytometry B Clin Cytom 72(5)):363\u2013370","journal-title":"Cytometry B Clin Cytom"},{"key":"711_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/10428190290006125","volume":"43","author":"AJ Bass","year":"2002","unstructured":"Bass AJ, Gong J, Nelson R, Rizzieri DA (2002) CD52 expression in mantle cell lymphoma. Leuk Lymphoma 43:339\u2013342. doi:10.1080\/10428190290006125","journal-title":"Leuk Lymphoma"},{"key":"711_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2169\/internalmedicine.46.1782","volume":"46","author":"K Tobinai","year":"2007","unstructured":"Tobinai K (2007) Antibody therapy for malignant lymphoma. Intern Med 46:99\u2013100. doi:10.2169\/internalmedicine.46.1782","journal-title":"Intern Med"},{"issue":"Suppl 1","key":"711_CR24","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.3816\/CLM.2006.s.005","volume":"7","author":"A Goy","year":"2006","unstructured":"Goy A (2006) New directions in the treatment of mantle cell lymphoma: an overview. Clin Lymphoma Myeloma 7(Suppl 1):S24\u2013S32. doi:10.3816\/CLM.2006.s.005","journal-title":"Clin Lymphoma Myeloma"},{"key":"711_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301\u2013305. doi:10.1126\/science.1071059","journal-title":"Science"},{"key":"711_CR26","first-page":"316","volume":"18","author":"J Klastersky","year":"2006","unstructured":"Klastersky J (2006) Adverse effects of the humanized antibodies used as cancer therapeutics. Curr Opin Immunol 18:316\u2013320","journal-title":"Curr Opin Immunol"},{"key":"711_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00262-002-0320-4","volume":"51","author":"S Huang","year":"2002","unstructured":"Huang S, Preuss KD, Xie X, Regitz E, Pfreundschuh M (2002) Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol Immunother 51:655\u2013662. doi:10.1007\/s00262-002-0320-4","journal-title":"Cancer Immunol Immunother"},{"key":"711_CR28","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1158\/1078-0432.CCR-04-2425","volume":"11","author":"M Hoogendoorn","year":"2005","unstructured":"Hoogendoorn M, Olde WJ, Smit WM, Schaafsma MR, Jedema I, Barge RM, Willemze R, Falkenburg JH (2005) Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation. Clin Cancer Res 11:5310\u20135318. doi:10.1158\/1078-0432.CCR-04-2425","journal-title":"Clin Cancer Res"},{"key":"711_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2141.2005.05604.x","volume":"130","author":"M Hishizawa","year":"2005","unstructured":"Hishizawa M, Imada K, Sakai T, Ueda M, Uchiyama T (2005) Identification of APOBEC3B as a potential target for the graft-versus-lymphoma effect by SEREX in a patient with mantle cell lymphoma. Br J Haematol 130:418\u2013421. doi:10.1111\/j.1365-2141.2005.05604.x","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-009-0711-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0711-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0711-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:37:35Z","timestamp":1744148255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-009-0711-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,24]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0711-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2009,2,24]]},"assertion":[{"value":"20 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}